Getting Started With Ray Blanco’s FDA Profit Alert (Day 2 of 7)
On Dec. 12, 2019, Sarepta Therapeutics’ stock didn’t move much. But after-hours that night, the company announced approval for their treatment of Duchenne muscular dystrophy. The next morning the company’s stock jumped over 30% in one day. And if you...
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Ray Blanco’s FDA Profit Alert
The FDA Profit Alert focuses on medical tech stocks with prices that move based on triggers generally unknown to the market. It is designed to alert you to breakout moves in the medical markets that could ultimately drive huge stock market gains. It’s the single best way to connect the dots that link today’s dynamic, innovative medical market.